Literature DB >> 15871520

Malignant glioma-induced neuronal cell death in an organotypic glioma invasion model. Technical note.

Ilker Y Eyüpoglu1, Eric Hahnen, Alexandra Heckel, Florian A Siebzehnrübl, Rolf Buslei, Rudolf Fahlbusch, Ingmar Blümcke.   

Abstract

Rapid growth and diffuse brain infiltration are hallmarks of malignant gliomas. The underlying molecular pathomechanisms of these tumors, however, remain to be determined. The authors present a novel glioma invasion model that allows researchers to monitor consecutively tumor cell proliferation and migration in an organotypic brain environment. Enhanced green fluorescent protein-labeled F98 rat glioma cells were implanted into slice cultures obtained from a rat hippocampus, and tumor growth was microscopically documented up to 20 days in vitro. Invasion along radially oriented migratory streams could be observed 5 days after implantation of rat F98, human U87MG, and mouse GL261 glioma cells, whereas human Be(2)c neuroblastoma cells and mouse HT22 hippocampal neurons failed to invade the brain parenchyma. Following implantation of F98 glioma cells into the entorhinal cortex, cell death was observed within the infiltrated brain parenchyma as well as in the neuroanatomically connected dentate gyrus. Application of the N-methyl-D-aspartate receptor antagonist MK801 to the culture medium significantly reduced neuronal degeneration in the dentate gyrus, whereas the alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate receptor antagonist GYKI 52466 inhibited peritumoral cytotoxicity. This new model allows researchers to address in a systematic manner the molecular pathways of brain invasion as well as specific tumor-host interactions such as necrosis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15871520     DOI: 10.3171/jns.2005.102.4.0738

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  21 in total

1.  Metformin inhibits proliferation and migration of glioblastoma cells independently of TGF-β2.

Authors:  Corinna Seliger; Anne-Louise Meyer; Kathrin Renner; Verena Leidgens; Sylvia Moeckel; Birgit Jachnik; Katja Dettmer; Ulrike Tischler; Valeria Gerthofer; Lisa Rauer; Martin Uhl; Martin Proescholdt; Ulrich Bogdahn; Markus J Riemenschneider; Peter J Oefner; Marina Kreutz; Arabel Vollmann-Zwerenz; Peter Hau
Journal:  Cell Cycle       Date:  2016-05-10       Impact factor: 4.534

2.  Glioblastoma cells vampirize WNT from neurons and trigger a JNK/MMP signaling loop that enhances glioblastoma progression and neurodegeneration.

Authors:  Marta Portela; Varun Venkataramani; Natasha Fahey-Lozano; Esther Seco; Maria Losada-Perez; Frank Winkler; Sergio Casas-Tintó
Journal:  PLoS Biol       Date:  2019-12-17       Impact factor: 8.029

3.  MIF-CD74 signaling impedes microglial M1 polarization and facilitates brain tumorigenesis.

Authors:  A Ghoochani; M A Schwarz; E Yakubov; T Engelhorn; A Doerfler; M Buchfelder; R Bucala; N E Savaskan; I Y Eyüpoglu
Journal:  Oncogene       Date:  2016-05-09       Impact factor: 9.867

4.  Annexin A2 promotes glioma cell invasion and tumor progression.

Authors:  Haiyan Zhai; Suchitra Acharya; Iordanis Gravanis; Saira Mehmood; Roberta J Seidman; Kenneth R Shroyer; Katherine A Hajjar; Stella E Tsirka
Journal:  J Neurosci       Date:  2011-10-05       Impact factor: 6.167

5.  Detection of remote neuronal reactions in the Thalamus and Hippocampus induced by rat glioma using the PET tracer cis-4-[¹⁸F]fluoro-D-proline.

Authors:  Stefanie Geisler; Antje Willuweit; Michael Schroeter; Karl Zilles; Kurt Hamacher; Norbert Galldiks; Nadim J Shah; Heinz H Coenen; Karl-Josef Langen
Journal:  J Cereb Blood Flow Metab       Date:  2013-02-06       Impact factor: 6.200

6.  In vivo bioluminescence imaging in an experimental mouse model for dendritic cell based immunotherapy against malignant glioma.

Authors:  W Maes; C Deroose; V Reumers; O Krylyshkina; R Gijsbers; V Baekelandt; J Ceuppens; Z Debyser; S W Van Gool
Journal:  J Neurooncol       Date:  2008-09-12       Impact factor: 4.130

7.  DC vaccination with anti-CD25 treatment leads to long-term immunity against experimental glioma.

Authors:  Wim Maes; Georgina Galicia Rosas; Bert Verbinnen; Louis Boon; Steven De Vleeschouwer; Jan L Ceuppens; Stefaan W Van Gool
Journal:  Neuro Oncol       Date:  2009-03-31       Impact factor: 12.300

8.  CRN2 enhances the invasiveness of glioblastoma cells.

Authors:  Anja Ziemann; Simon Hess; Ridhirama Bhuwania; Stefan Linder; Peter Kloppenburg; Angelika A Noegel; Christoph S Clemen
Journal:  Neuro Oncol       Date:  2013-02-14       Impact factor: 12.300

9.  In vivo glioblastoma growth is reduced by apyrase activity in a rat glioma model.

Authors:  Fernanda B Morrone; Diogo L Oliveira; Patrícia Gamermann; Joseli Stella; Suzana Wofchuk; Márcia R Wink; Luise Meurer; Maria Isabel A Edelweiss; Guido Lenz; Ana Maria O Battastini
Journal:  BMC Cancer       Date:  2006-09-23       Impact factor: 4.430

10.  PPAR Gamma Activators: Off-Target Against Glioma Cell Migration and Brain Invasion.

Authors:  Sebastian Seufert; Roland Coras; Christian Tränkle; Darius P Zlotos; Ingmar Blümcke; Lars Tatenhorst; Michael T Heneka; Eric Hahnen
Journal:  PPAR Res       Date:  2008       Impact factor: 4.964

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.